Category: Biotechnology company
Quick infos Headquarters: Newark, Delaware, United States Trade prices Volume: Market Cap: 310.09M Prev closed: 1.61 Open: 2.52 High: 2.69 Low: 2.07 52 week low: 0.05 52 week high: 3.4 Dividends: No Dividends Next ER: November 16, 2020 After Market Closes
Company Profile iBio, Inc. (NYSE MKT: IBIO), a leader in the plant-made pharmaceutical field, develops and offers pharmaceutical product applications using its iBio Technology platform.
Earnings History Date EPS / Forecast Revenue / Forecast November 16, 2020 - / -0.08- / 100KOctober 14, 2020 -0.05 / -0.05100K / 100KSeptember 2, 2020 -0.05 / -0.05100K / 100KJune 3, 2020 -0.06 / -100K / -Beat! February 26, 2020 -0.69 / -314.0K / -Beat! view more
Historical Data Date Price Open High Low Vol Change ER Dec 11, 2020 1.2000 1.2800 1.2900
1.2000
11.96M 2.56% Dec 10, 2020 1.1700 1.2100 1.2100
1.1500
15.23M -5.65% Dec 9, 2020 1.2400 1.3200 1.3300
1.1800
16.68M -5.34% Dec 8, 2020 1.3100 1.2700 1.3900
1.2700
50.23M -12.67% Dec 7, 2020 1.5000 1.5300 1.5400
1.4700
8.68M 0.67% Dec 4, 2020 1.4900 1.4800 1.5200
1.4700
7.48M -1.97% Dec 3, 2020 1.5200 1.6000 1.6300
1.4800
11.05M -4.4% Dec 2, 2020 1.5900 1.6000 1.7500
1.5300
34.08M 9.66% Dec 1, 2020 1.4500 1.4500 1.4800
1.4400
5.15M -2.68% Nov 30, 2020 1.4900 1.4700 1.5100
1.4300
7.13M -1.32% view more
NASDAQ - Nasdaq Stock Market
More profiles and info about the company News
ETFs with exposure to iBio, Inc. : December 8, 2017 capitalcube.com Oct 15, 2020 1:03 pm
iBio Announces Collaboration with EdgePoint AI for Next Gen Quality in Biologics Manufacturing finance.yahoo.com Oct 15, 2020 8:30 am iBio stock surges 19% premarket on hopes for plans to develop plant-based coronavirus vaccine marketwatch.com Oct 15, 2020 8:07 am
iBio and Planet Biotechnology Enter into Exclusive Worldwide License Agreement for the Development of a COVID-19 Therapeutic finance.yahoo.com Oct 15, 2020 7:15 am
iBio to be Added to the Russell 2000® and Russell 3000® Indexes finance.yahoo.com Oct 15, 2020 6:45 am Inovio (+27%) adds to corporate update-stoked rally seekingalpha.com Sep 17, 2020 1:31 am iBio +14% on advancement of IBIO-201, COVID-19 LicKM-subunit vaccine seekingalpha.com Sep 9, 2020 9:06 pm COVID-19 vaccine developers rally on AstraZeneca study pause seekingalpha.com Sep 9, 2020 6:37 pm
Why iBio Stock Is Soaring Today fool.com Sep 9, 2020 11:58 am
Is CureVac a Buy on the Pullback? It Depends finance.yahoo.com Sep 3, 2020 3:29 pm
Why ADMA Biologics, iBio, and Kamada Are Jumping Today fool.com Aug 24, 2020 8:42 am
Xerox and Inozyme See Activist Action barrons.com Aug 14, 2020 4:55 pm
IBio's stock soars, but Novavax and Inovio stocks fall amid news on other COVID-19 vaccine candidates marketwatch.com Jul 20, 2020 10:17 am NIH begs to differ on FDA's EUA for convalescent plasma for COVID-19 seekingalpha.com Sep 2, 2020 3:48 am AstraZeneca starts U.S. final-stage trial of COVID-19 vaccine seekingalpha.com Sep 1, 2020 2:45 pm IBio jumps into COVID-19 therapy race with Planet Biotech deal seekingalpha.com Aug 28, 2020 8:03 pm Sanofi plans to start human testing of COVID-19 vaccine - Bloomberg seekingalpha.com Aug 27, 2020 9:46 pm Can you get coronavirus a second time? A new study says yes seekingalpha.com Aug 25, 2020 3:43 pm IBio rallies on wave of convalescent plasma-stoked buying seekingalpha.com Aug 24, 2020 7:35 pm Investors in COVID-19 stocks face turmoil in coming weeks on vaccine data readouts seekingalpha.com Aug 22, 2020 2:00 pm This company doesn't provide a dividend.
Talk about iBio, Inc. below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
If you want to help pay for server cost or for improving this tool. You can send it via Paypal .
Buy on Amazon While many books explain the how of bitcoin, The Internet of Money delves into the why of bitcoin. Acclaimed information-security expert and author of Mastering Bitcoin, Andreas M. Antonopoulos examines and contextualizes the significance of bitcoin through a series of essays spanning the exhilarating maturation of this technology.
